Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-2.62

-1.8

-0.98

-0.16

Details

Expected EPS

-1.2007567372799999

Actual EPS

-1.6441343999999998

Surprise EPS

-0.44

Surprise Percent

+36.92%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -1.6441343999999998 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.